Regression of CD8+ pseudolymphoma after HIV antiviral triple therapy

Journal of the American Academy of Dermatology

Volumn 49, Issue 1, 2003, Pages 139-141

  Schartz, Noël Emile Célestin ^b   De La Blanchardiére, Arnaud ^b   Alaoui, Siham ^b   Morel, Patrice ^b   Sigaux, François ^b   Vignon Pennamen, Marie Dominique ^b   Flageul, Béatrice ^b   Lebbé, Céleste ^a  

^a SAINT LOUIS HOSPITAL   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; BETAMETHASONE VALERATE; CD8 ANTIGEN; INDINAVIR; LAMIVUDINE; STAVUDINE; ZIDOVUDINE;

ADULT; ARTICLE; CASE REPORT; CYTOTOXIC T LYMPHOCYTE; DEATH; DIFFERENTIAL DIAGNOSIS; ERYTHEMA; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERKERATOSIS; HYPOPIGMENTATION; IMMUNOHISTOCHEMISTRY; LYMPHOCYTE COUNT; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; PRURITUS; PSEUDOLYMPHOMA; SEZARY SYNDROME; SKIN BIOPSY; T CELL LYMPHOMA; VIRUS LOAD; VITILIGO;

EID: 0038385522     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2003.299     Document Type: Article

References (11)

1. Zhang P, Chiriboga L, Jacobson M, Marsh E, Hennessey P, Schinella R, et al. Mycosis fungoides-like T cell cutaneous lymphoid infiltrates in patients with HIV infection. Am J Dermatopathol 1995;17:29-35.
2. Picard-Dahan C, Le Guyadec T, Grossin M, Fenton N, Raphael M, Simonpoli AM, et al. Erythrodermies pigmentées au cours du SIDA. Ann Dermatol Venereol 1996;123:307-13.
3. Guitart J, Variakojis D, Kuzel T, Rosen S. Cutaneous CD8+ T-cell infiltrates in advanced HIV infection. J Am Acad Dermatol 1999; 41:722-7.
4. Brodt HR, Kamps BS, Gute P, Knupp B, Staszewski S, Helm EB. Changing incidence of AIDS-defining illnesses in the era of antiretroviral combination therapy. AIDS 1997;11:1731-8.
5. Jones JL, Hanson DL, Dworkin MS, Ward JW, Jaffe HW, the Adult/Adolescent Spectrum of HIV Disease Project Group. Effect of antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. J Acquir Immune Defic Syndr 1999;21:S11-7.
6. Buchbinder SP, Holmberg SD, Scheer S, Colfax G, O'Malley P, Vittinghoff E. Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 1999;21:S23-6.
7. Rabkin CS, Testa MA, Huang J, Van Roenn JH. Kaposi's sarcoma and non-Hodgkin's lymphoma incidence trends in AIDS clinical trial group study participants. J Acquire Immune Defic Syndr 1999;21:S31-3.
8. Nikkels AE, Pierard GE. Are granulomatous reactions in old zoster lesions due to an immune response to varicella-zoster virus envelope glucoproteins? Clin Exp Dermatol 1998;23:230-40.
9. Mirmirani P, Maurer TA, Herndier B, McGrath M, Weinstein MD, Berger TG. Sarcoidosis in a patient with AIDS: a manifestation of immune restoration syndrome. J Am Acad Dermatol 1999;41: 285-6.
10. Bachelez H, Hadida F, Parizot C, Flageul B, Kemula M, Dubertret L, et al. Oligoclonal expansion of HIV-specific cytotoxic CD8 T lymphocytes in the skin of HIV-1 infected patients with cutaneous pseudolymphoma. J Clin Invest 1998;101:2506-16.
11. Bachelez H, Hadida F, Gorochov G. Massive infiltration of the skin by HIV specific cytotoxic CD8+ cells. N Engl J Med 1996;335: 61-2.